PRE 14A

PRE 14A Filing

Company: Processa Pharmaceuticals, Inc.
Filed: April 14, 2023
Period of Report: April 14, 2023
Accession Number: 0001493152-23-012317

View Document ↗ View on SEC.gov ↗